FUL
Neutral signalScored 2026-10-20 Drivers: trend, fundamentals. Insiders: neutral. Moteurs : tendance, fondamentaux. Initiés : neutre.
Research, not advice.
À propos
H.B. Fuller Company
- Nom
- H.B. Fuller Company
- Secteur
- Basic Materials
- Industrie
- Chemicals - Specialty
- Bourse
- NYSE
- Capitalisation
- $2.7B
- Employés
- 7,100
- PDG
- Celeste Mastin
- Site web
- https://www.hbfuller.com
- Marché
- AVNTCBTCENXHWKNOLNPRM
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Building Adhesive Solutions. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives, such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven and hygiene, and medical and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives comprising reactive, light cure, two-part liquids, polyurethane, silicone, film, and fast cure products to the durable assembly, performance wood and textile, transportation, electronics, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly to customers, as well as through distributors and retailers in North America, Latin America, Europe, India, the Middle East, Africa, and the Asia Pacific. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
ACHAT TOTAL: 8 539,599 titres (~422 511,29 $ US)
- Insiders
- Happe Michael JMartin Celine ChristineFLORNESS DANIEL LLauber Charles TZaheer Srilata
- Total bought
-
$422,511
Avg buy (VWAP, 90d window) $49.53 vs last close $49.13 (-0.8%)
- Total sold
-
$593,332
Avg sell (VWAP, 90d window) $62.06 vs last close $49.13 (-20.8%)
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-09-30
- Liquidity
- Liquid $39,266,197/day · 20d vol
- Last synced
-
2026-10-26 21:10:28
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-10-16 | Malik Muhammad Shahbaz | Buy · P | 479 | $52.23 | $25,000 | Form 4 |
| 2026-09-30 | Martin Celine Christine | Buy · P | 465 | $49.50 | $22,998 | Form 4 |
| 2026-09-29 | Happe Michael J | Buy · P | 2,000 | $49.62 | $99,250 | Form 4 |
| 2026-09-29 | Lauber Charles T | Buy · P | 2,005 | $49.87 | $99,985 | Form 4 |
| 2026-09-29 | Zaheer Srilata | Buy · P | 40 | $49.97 | $1,999 | Form 4 |
| 2026-09-28 | FLORNESS DANIEL L | Buy · P | 2,030 | $49.34 | $100,160 | Form 4 |
| 2026-09-28 | Rasmussen Trangsrud Teresa J | Buy · P | 1,542 | $48.96 | $75,494 | Form 4 |
| 2026-09-28 | Zaheer Srilata | Buy · P | 2,000 | $49.06 | $98,120 | Form 4 |
| 2026-08-11 | Weaver Nathan D. | Sell · S | 9,561 | $62.06 | $593,332 | Form 4 |
| 2026-04-17 | Rasmussen Trangsrud Teresa J | Buy · P | 1,000 | $65.83 | $65,830 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2019-03-25 | Van Taylor | Sale (Full) | $1,001 - $15,000 |
Signal
Neutral signalScored 2026-10-20 Drivers: trend, fundamentals. Insiders: neutral. Moteurs : tendance, fondamentaux. Initiés : neutre.
FUL presents a moderate risk/reward profile: improving EBITDA margins and consistent cash flow generation are partially offset by elevated debt (3.6x EBITDA) and deteriorating short-term liquidity ratios.
The first sentence of the analysis written for FUL on 2026-10-20 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Unavailable or mixed. Purchase and sale value are mixed
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Timing Pulls against a bullish reading. Close is more than 0.5 ATR under stored support
- Financial indicators Supports a bullish reading. Current ratio 1.70 · operating margin 11%
Suggested stop 48.07, nearest stored support minus 0.5 ATR(2.2% under the last close). Reward/risk to the next stored resistance is 2.82. Research, not advice. Not an order.
Recent news
- 2026-10-19 H.B. Fuller Rejects Ancora''s Latest Acquisition Bid, Plans to Consider Selling Noncore Businesses Company says Ancora''s revised cash offer of $1.2 billion to $1.4 billion still undervalues its building adhesives solutions business.
- 2026-10-19 H.B. Fuller Board Unanimously Rejects Second Unsolicited, Non-Binding Proposal for Building Adhesive Solutions Segment ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (“H.B. Fuller” or “the Company”) (NYSE: FUL), the world''s largest pureplay adhesives company, today announced that following a thorough review supported by independent financial and legal advisors, its Board of Directors has unanimously rejected Ancora''s second unsolicited, non-binding proposal to acquire its Building Adhesive Solutions (“BAS”) business for between $1.2 billion and $1.4 billion in cash. The Board determined that the modest o.
- 2026-10-15 H.B. Fuller Prices $850M Debt Offering to Fund AMS Acquisition FUL prices $850M in senior notes to finance its AMS acquisition and refinance debt, with a 7.625% coupon and a key redemption condition tied to the deal.
- 2026-10-08 H.B. Fuller Announces Pricing of $850 Million Debt Offering ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (“H.B. Fuller”) (NYSE:FUL) announced today that it has priced an offering of $850 million aggregate principal amount of 7.625% new senior unsecured notes due 2034 (the “Notes”) at an issue price of 100% of the principal amount, in a private offering (the “Notes Offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The issuance of the Notes is expected to close on or abo.
- 2026-10-08 Enerpac Tool Group Elects Charles T. Lauber as New Director MILWAUKEE, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Enerpac Tool Group Corp. (NYSE: EPAC) (the “Company” or “Enerpac”) announced today that the Board of Directors is expanding the size of the Board from eight to nine directors and has elected Charles T. Lauber to its Board effective today.
- 2026-10-02 H. B. Fuller (FUL) is a Top-Ranked Value Stock: Should You Buy? Whether you''re a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 2026-10-02 H. B. Fuller (NYSE:FUL) Director Celine Christine Martin Buys 465 Shares of Company Stock H. B. Fuller Company (NYSE: FUL - Get Free Report) Director Celine Martin purchased 465 shares of H. B. Fuller stock in a transaction that occurred on Wednesday, September 30th. The stock was purchased at an average cost of $49.50 per share, for a total transaction of $23,017.50. Following the completion of the purchase, the director
- 2026-10-01 H.B. Fuller Announces Quarterly Dividend ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.2450 per share of common stock, payable on October 29, 2026 to shareholders of record at the close of business on October 15, 2026. H.B. Fuller has paid quarterly cash dividends on its common stock for 58 consecutive years. About H.B. Fuller As the largest pureplay adhesives company in the world, H.B. Fuller''s (NYSE: FUL) innovative, func.
- 2026-09-29 Ancora Submits Significantly Enhanced Proposal to Acquire H.B. Fuller''s Building Adhesive Solutions Segment for up to $1.4 Billion in Cash CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group, LLC (together with its affiliates, “Ancora” or “we”), a meaningful shareholder of H.B. Fuller Company (NYSE: FUL) (“H.B. Fuller” or the “Company”), today sent a letter to the Company''s Board of Directors regarding an enhanced proposal to acquire H.B. Fuller''s Building Adhesive Solutions segment for between $1.2 billion and $1.4 billion in cash. Ancora has also obtained a “highly confident” letter from Fortress Investment Group related to being.
- 2026-09-28 H.B. Fuller Appoints R. Jeffrey Bailly to Board of Directors ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (“H.B. Fuller” or “the Company”) (NYSE: FUL), the world''s largest pureplay adhesives company, today announced the appointment of R. Jeffrey Bailly to its Board of Directors, effective immediately. In connection with this appointment, Ruth Kimmelshue will be stepping down from the Board. “Jeff brings highly relevant operating and leadership experience across key medical end markets as we focus on accelerating our path to greater than 20% adju.
Market snapshot
Financial ratios
| Metric | Trend | 2025-11-29 | 2024-11-30 | 2023-12-02 | 2022-12-03 | 2021-11-27 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 31.7% | 30.1% | 29.2% | 25.7% | 25.8% | |
| Ebit Margin | 10.0% | 8.8% | 10.5% | 9.2% | 9.0% | |
| Ebitda Margin | 15.2% | 13.7% | 15.1% | 13.1% | 13.4% | |
| Operating Profit Margin | 11.5% | 10.3% | 10.8% | 8.6% | 7.8% | |
| Pretax Profit Margin | 6.3% | 5.2% | 6.8% | 6.9% | 6.8% | |
| Continuous Operations Profit Margin | 4.4% | 3.7% | 4.1% | 4.8% | 4.9% | |
| Net Profit Margin | 4.4% | 3.6% | 4.1% | 4.8% | 4.9% | |
| Bottom Line Profit Margin | 4.4% | 3.6% | 4.1% | 4.8% | 4.9% | |
| Current Ratio | 1.699 | 1.806 | 1.894 | 1.841 | 1.657 | |
| Quick Ratio | 1.064 | 1.156 | 1.256 | 1.144 | 1.049 | |
| Solvency Ratio | 0.104 | 0.098 | 0.103 | 0.115 | 0.114 | |
| Cash Ratio | 0.144 | 0.235 | 0.259 | 0.113 | 0.084 | |
| Price To Earnings Ratio | 20.964 | 32.443 | 28.798 | 23.837 | 24.230 | |
| Price To Earnings Growth Ratio | 1.212 | -2.887 | -1.386 | 2.272 | 0.861 | |
| Forward Price To Earnings Growth Ratio | 1.212 | -2.887 | -1.386 | 2.272 | 0.861 | |
| Price To Earnings Diluted Ratio | 21.193 | 33.430 | 29.687 | 24.641 | 24.882 | |
| Price To Earnings Diluted Growth Ratio | 1.083 | -2.986 | -1.444 | 2.524 | 0.963 | |
| Price To Book Ratio | 1.589 | 2.310 | 2.380 | 2.673 | 2.448 | |
| Price To Sales Ratio | 0.916 | 1.184 | 1.190 | 1.148 | 1.192 | |
| Price To Free Cash Flow Ratio | 26.252 | 25.881 | 16.113 | 34.011 | 33.340 | |
| Price To Operating Cash Flow Ratio | 12.077 | 13.966 | 11.040 | 16.779 | 18.322 | |
| Debt To Assets Ratio | 0.389 | 0.421 | 0.403 | 0.403 | 0.386 | |
| Debt To Equity Ratio | 1.007 | 1.135 | 1.084 | 1.118 | 1.033 | |
| Debt To Capital Ratio | 0.502 | 0.532 | 0.520 | 0.528 | 0.508 | |
| Long Term Debt To Capital Ratio | 0.502 | 0.524 | 0.511 | 0.519 | 0.499 | |
| Financial Leverage Ratio | 2.587 | 2.698 | 2.691 | 2.772 | 2.677 | |
| Working Capital Turnover Ratio | 6.317 | 5.952 | 5.789 | 6.956 | 6.731 | |
| Operating Cash Flow Ratio | 0.354 | 0.420 | 0.546 | 0.363 | 0.289 | |
| Operating Cash Flow Sales Ratio | 0.076 | 0.085 | 0.108 | 0.068 | 0.065 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.460 | 0.540 | 0.685 | 0.493 | 0.550 | |
| Debt Service Coverage Ratio | 3.449 | 3.247 | 3.189 | 3.433 | 3.639 | |
| Interest Coverage Ratio | 2.993 | 2.771 | 2.819 | 3.521 | 3.274 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 515.225 | 205.539 | 8.888 | 8.538 | |
| Operating Cash Flow Coverage Ratio | 0.131 | 0.146 | 0.199 | 0.143 | 0.129 | |
| Capital Expenditure Coverage Ratio | 1.852 | 2.172 | 3.176 | 1.974 | 2.220 | |
| Dividend Paid And Capex Coverage Ratio | 1.368 | 1.619 | 2.328 | 1.516 | 1.629 | |
| Dividend Payout Ratio | 0.331 | 0.365 | 0.299 | 0.217 | 0.216 | |
| Enterprise Value Multiple | 9.661 | 12.496 | 11.163 | 12.283 | 12.545 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 31.7% | ▲1.6% | ▲3.2% |
| Ebit Margin | 10.0% | ▲1.2% | ▲0.5% |
| Ebitda Margin | 15.2% | ▲1.4% | ▲1.1% |
| Operating Profit Margin | 11.5% | ▲1.1% | ▲1.7% |
| Pretax Profit Margin | 6.3% | ▲1.1% | ▼-0.1% |
| Continuous Operations Profit Margin | 4.4% | ▲0.7% | -0.0% |
| Net Profit Margin | 4.4% | ▲0.7% | -0.0% |
| Bottom Line Profit Margin | 4.4% | ▲0.7% | -0.0% |
| Current Ratio | 1.699 | ▼-0.107 | ▼-0.080 |
| Quick Ratio | 1.065 | ▼-0.092 | ▼-0.069 |
| Solvency Ratio | 0.104 | ▲0.006 | ▼-0.003 |
| Cash Ratio | 0.144 | ▼-0.091 | ▼-0.023 |
| Price To Earnings Ratio | 20.964 | ▼-11.479 | ▼-5.090 |
| Price To Earnings Growth Ratio | 1.212 | ▲4.099 | ▲1.198 |
| Forward Price To Earnings Growth Ratio | 1.212 | ▲4.099 | ▲1.198 |
| Price To Earnings Diluted Ratio | 21.193 | ▼-12.238 | ▼-5.574 |
| Price To Earnings Diluted Growth Ratio | 1.083 | ▲4.069 | ▲1.055 |
| Price To Book Ratio | 1.589 | ▼-0.721 | ▼-0.691 |
| Price To Sales Ratio | 0.916 | ▼-0.267 | ▼-0.210 |
| Price To Free Cash Flow Ratio | 26.252 | ▲0.371 | ▼-0.867 |
| Price To Operating Cash Flow Ratio | 12.077 | ▼-1.889 | ▼-2.360 |
| Debt To Assets Ratio | 0.389 | ▼-0.031 | ▼-0.011 |
| Debt To Equity Ratio | 1.007 | ▼-0.128 | ▼-0.068 |
| Debt To Capital Ratio | 0.502 | ▼-0.030 | ▼-0.016 |
| Long Term Debt To Capital Ratio | 0.502 | ▼-0.022 | ▼-0.009 |
| Financial Leverage Ratio | 2.587 | ▼-0.111 | ▼-0.098 |
| Working Capital Turnover Ratio | 6.317 | ▲0.365 | ▼-0.032 |
| Operating Cash Flow Ratio | 0.354 | ▼-0.066 | ▼-0.040 |
| Operating Cash Flow Sales Ratio | 0.076 | ▼-0.009 | ▼-0.004 |
| Free Cash Flow Operating Cash Flow Ratio | 0.460 | ▼-0.080 | ▼-0.086 |
| Debt Service Coverage Ratio | 3.449 | ▲0.203 | ▲0.058 |
| Interest Coverage Ratio | 2.993 | ▲0.222 | ▼-0.083 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | ▼-515.225 | ▼-147.638 |
| Operating Cash Flow Coverage Ratio | 0.131 | ▼-0.015 | ▼-0.019 |
| Capital Expenditure Coverage Ratio | 1.852 | ▼-0.320 | ▼-0.427 |
| Dividend Paid And Capex Coverage Ratio | 1.369 | ▼-0.250 | ▼-0.324 |
| Dividend Payout Ratio | 0.331 | ▼-0.035 | ▲0.045 |
| Enterprise Value Multiple | 9.661 | ▼-2.835 | ▼-1.969 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $3.18B | $4.22B | $4.18B | $4.30B | $3.91B | |
| Enterprise value | $5.09B | $6.13B | $5.90B | $6.02B | $5.50B | |
| EV / Sales | 1.47x | 1.72x | 1.68x | 1.61x | 1.68x | |
| EV / Op. cash flow | 19.32x | 20.27x | 15.59x | 23.48x | 25.77x | |
| EV / Free cash flow | 42.01x | 37.55x | 22.76x | 47.60x | 46.88x | |
| EV / EBITDA | 9.66x | 12.50x | 11.16x | 12.28x | 12.54x | |
| Net debt / EBITDA | 3.62x | 3.88x | 3.26x | 3.51x | 3.62x | |
| Current ratio | 1.70x | 1.81x | 1.89x | 1.84x | 1.66x | |
| Income quality | 1.73x | 2.32x | 2.61x | 1.42x | 1.32x | |
| Graham number | $48 | $42 | $44 | $48 | $46 | |
| Graham net-net | -$44 | -$41 | -$39 | -$38 | -$36 | |
| Tax burden | 69.3% | 69.7% | 60.8% | 70.0% | 71.9% | |
| Interest burden | 62.9% | 59.1% | 64.7% | 75.0% | 76.1% | |
| Working capital | $519.9M | $579.9M | $619.3M | $593.6M | $484.3M | |
| Invested capital | $3.94B | $3.83B | $3.71B | $3.42B | $3.17B | |
| Return on assets | 2.9% | 2.6% | 3.1% | 4.0% | 3.8% | |
| Operating ROA | 7.9% | 7.6% | 8.3% | 7.4% | 6.2% | |
| Return on tangible assets | 5.6% | 5.0% | 5.8% | 7.6% | 7.1% | |
| Return on equity | 7.6% | 7.1% | 8.3% | 11.2% | 10.1% | |
| Return on invested capital | 6.2% | 6.1% | 5.7% | 5.9% | 5.1% | |
| Return on capital employed | 9.0% | 8.8% | 9.4% | 8.6% | 7.2% | |
| Earnings yield | 4.8% | 3.1% | 3.5% | 4.2% | 4.1% | |
| Free cash flow yield | 3.8% | 3.9% | 6.2% | 2.9% | 3.0% | |
| Capex / Op. cash flow | 54.0% | 46.0% | 31.5% | 50.7% | 45.0% | |
| Capex / Depreciation | 79.8% | 79.7% | 74.5% | 88.4% | 67.1% | |
| Capex / Sales | 4.1% | 3.9% | 3.4% | 3.5% | 2.9% | |
| SG&A / Sales | 20.2% | 18.4% | 17.0% | 15.9% | 16.8% | |
| R&D / Sales | 0.0% | 1.4% | 1.4% | 1.2% | 1.2% | |
| Stock comp / Sales | 0.0% | 0.6% | 0.6% | 0.6% | 0.7% | |
| Intangibles / Total assets | 48.0% | 46.7% | 46.9% | 46.9% | 46.5% | |
| Days sales outstanding | 59d | 61d | 64d | 63d | 72d | |
| Days payables outstanding | 72d | 72d | 65d | 60d | 75d | |
| Operating cycle | 132d | 130d | 129d | 127d | 139d | |
| Cash conversion cycle | 60d | 58d | 65d | 67d | 64d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years